Tixagevimab + Cilgavimab: First Approval
Susan J. Keam
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)VaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPost-exposure prophylaxisAuthorizationDrug approvalPediatricsIntensive care medicineEmergency medicineImmunologyInternal medicineDrugVirologyPharmacologyOutbreakInfectious disease (medical specialty)DiseaseHuman immunodeficiency virus (HIV)Computer scienceComputer securitySARS-CoV-2 and COVID-19 ResearchImmunodeficiency and Autoimmune DisordersCOVID-19 Clinical Research Studies